203 related articles for article (PubMed ID: 20101010)
1. Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis.
Tu ST; Chang SJ; Chen JF; Tien KJ; Hsiao JY; Chen HC; Hsieh MC
Arch Intern Med; 2010 Jan; 170(2):155-61. PubMed ID: 20101010
[TBL] [Abstract][Full Text] [Related]
2. Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control.
Hsieh MC; Hsieh YT; Cho TJ; Chen JF; Lin SD; Chen HC; Tu ST
Eur J Clin Invest; 2011 Aug; 41(8):870-8. PubMed ID: 21299554
[TBL] [Abstract][Full Text] [Related]
3. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
Romero P; Salvat M; Fernández J; Baget M; Martinez I
J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
[TBL] [Abstract][Full Text] [Related]
4. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
Mormile A; Veglio M; Gruden G; Girotto M; Rossetto P; D'Este P; Cavallo-Perin P
Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
[TBL] [Abstract][Full Text] [Related]
5. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
[TBL] [Abstract][Full Text] [Related]
6. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
[TBL] [Abstract][Full Text] [Related]
7. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo Perin P;
Diabetes Care; 2003 Jul; 26(7):2150-5. PubMed ID: 12832328
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home.
Joseph J; Koka M; Aronow WS
J Am Med Dir Assoc; 2008 Jan; 9(1):51-4. PubMed ID: 18187113
[TBL] [Abstract][Full Text] [Related]
9. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy.
Ujihara N; Sakka Y; Takeda M; Hirayama M; Ishii A; Tomonaga O; Babazono T; Takahashi C; Yamashita K; Iwamoto Y
Diabetes Res Clin Pract; 2002 Nov; 58(2):109-14. PubMed ID: 12213352
[TBL] [Abstract][Full Text] [Related]
10. Ezetimibe reduces urinary albumin excretion in hypercholesterolaemic type 2 diabetes patients with microalbuminuria.
Nakamura T; Sato E; Amaha M; Kawagoe Y; Maeda S; Inoue H; Yamagishi SI
J Int Med Res; 2012; 40(2):798-803. PubMed ID: 22613445
[TBL] [Abstract][Full Text] [Related]
11. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
12. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
[TBL] [Abstract][Full Text] [Related]
13. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
14. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.
Torffvit O; Agardh CD
J Diabetes Complications; 2001; 15(6):307-13. PubMed ID: 11711324
[TBL] [Abstract][Full Text] [Related]
15. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
[TBL] [Abstract][Full Text] [Related]
16. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.
Cederholm J; Eliasson B; Nilsson PM; Weiss L; Gudbjörnsdottir S;
Diabetes Res Clin Pract; 2005 Mar; 67(3):258-66. PubMed ID: 15713359
[TBL] [Abstract][Full Text] [Related]
17. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
[TBL] [Abstract][Full Text] [Related]
18. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ; Forrest KY; Kuller LH; Becker DJ;
Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
20. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.
Hadjadj S; Duly-Bouhanick B; Bekherraz A; BrIdoux F; Gallois Y; Mauco G; Ebran J; Marre M
Diabetes Metab; 2004 Feb; 30(1):43-51. PubMed ID: 15029097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
